BI-1206 Earns Orphan Drug Designation as Mantle Cell Lymphoma Treatment
News
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to BioInvent’s antibody BI-1206 for the treatment of mantle cell lymphoma. “This orphan designation for BI-1206 is very good ... Read more